1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M


1 Year 1Y

5 Years 5Y

About Bruker Corp

Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scienti c instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with its customers, Bruker is enabling innovation, improved productivity and customer success in life science molecular research, in applied and pharma applications, in microscopy and nanoanalysis, and in industrial applications, as well as in cell biology, preclinical imaging, clinical phenomics and proteomics research and clinical microbiology.
Frank Laukien

40 Manning Rd
Billerica, Massachusetts 01821-3915
Phone: 19786633660


Bruker Offers Upside With Key Enabling Technologies For Future Bio-Pharma Research
Apr 11, 2024 20:43pm

No summary available.

Source:Seeking Alpha
Bruker Introduces Novel NMR Scientific Capabilities for Structural Biology Discoveries in Membrane Proteins and Protein Aggregates
Apr 08, 2024 11:20am
Bruker Advances Magnet Technology for Broader Adoption of NMR in Academic and Biopharma Research, and Process Analytical Technologies
Apr 08, 2024 11:20am
Bruker Corporation: Bruker Introduces Novel NMR Scientific Capabilities for Structural Biology Discoveries in Membrane Proteins and Protein Aggregates
Apr 08, 2024 11:06am

Bruker Corporation (Nasdaq: BRKR), the leading provider of nuclear magnetic resonance (NMR) spectroscopy solutions, announces the introduction of novel high-resolution solid-state NMR scientific c…

Source:Finanz Nachrichten
Bruker Introduces Novel NMR Scientific Capabilities for Structural Biology Discoveries in Membrane Proteins and Protein Aggregates | BRKR Stock News
Apr 08, 2024 11:00am

Bruker introduces novel high-resolution solid-state NMR scientific capabilities at the 65th ENC, enabling structural biology discoveries in large proteins, membrane proteins, and protein aggregates. The new ultra-fast CP/MAS iProbe with 160 kHz MAS system provides enhanced 1H-NMR resolution and T2'' times, advancing the study of biological samples. The introduction of standard-bore DNP Probes for 600 and 800 MHz expands solid-state DNP-NMR research accessibility, offering sensitivity enhancements of 50x to 200x.

Source:Stock Titan
Bruker Selected as ‘Company of the Year’ by Instrument Business Outlook
Apr 01, 2024 11:00am

Bruker Corporation (NASDAQ: BRKR) has been selected as the Instrument Business Outlook (IBO) ‘Company of the Year’ for 2023. IBO cited Bruker’s double-digit organic revenue growth in 2023 in all major regions, and in all business groups, demonstrating a transformed portfolio and operational strength. The IBO recognition follows Bruker’s three consecutive years of double-digit organic Jetzt den vollständigen Artikel lesen

Inquiry Into Agilent Technologies''s Competitor Dynamics In Life Sciences Tools & Services Industry
Mar 26, 2024 16:00pm

In the fast-paced and highly competitive business world of today, conducting thorough company analysis is essential for investors and industry observers. In this article, we will conduct an extensive industry comparison, evaluating Agilent Technologies (NYSE: A ) in relation to its major competitors in the Life Sciences Tools & Services industry. Through a detailed examination of key financial metrics, market standing, and growth prospects, our objective is to provide valuable insights and illuminate company''s performance in the industry. Agilent Technologies Background Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent''s measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab (consisting of consumables and services related to life science and applied tools), and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations.

PharmaVentures Ltd.: PharmaVentures acts as the exclusive M&A advisor on the successful sale of Phasefocus to Bruker
Mar 19, 2024 09:06am

LONDON, March 19, 2024 /PRNewswire/ -- PharmaVentures is pleased to announce that it acted as the exclusive advisor to Phasefocus Holdings Limited on its sale to Bruker (NASDAQGS:BRKR). Phasefocus…

Source:Finanz Nachrichten
Bruker Advances CCS-Enabled 4D-Proteomics timsTOF Solutions for Immunopeptidomes and Glycoproteomics at US HUPO
Mar 11, 2024 11:00am

PORTLAND, Ore.--(BUSINESS WIRE)---- $BRKR #BRKR--At the 20th US Human Proteome Organization Congress 2024, Bruker Corporation (Nasdaq: BRKR) announced progress in immunopeptidomics, glycoproteomics and other CCS-enabled 4D-proteomics workflows. The rapid advances in deep, at-scale proteomics, glycomics and peptidomics research solutions complement other performance-leading life-science tools for the post-genomic era by Bruker. Together they enable post-genomic molecular and cell biology research, with key insi

Source:Business Wire
Bruker Corporation: Bruker Announces Closing of Chemspeed Technologies AG Acquisition
Mar 07, 2024 12:06pm

Bruker Corporation (Nasdaq: BRKR) is pleased to announce the successful closing of its acquisition of Chemspeed Technologies AG, a leading Swiss provider of automated laboratory R&D and QC workflo…

Source:Finanz Nachrichten